Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grifols SA (DE:G0FB)
FRANKFURT:G0FB
Holding DE:G0FB?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.22Last Year’s EPS
0.09Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 05, 2018
|% Change Since: -15.63%
|Next Earnings Date:Jul 27, 2018
Earnings Call Sentiment|Neutral
The earnings call reflects a strong performance in revenue growth and EBITDA improvement, with strategic achievements in innovation and deleveraging. However, significant financial expenses and ongoing challenges in free cash flow generation present concerns. The situation in China also requires careful monitoring.Company Guidance
During Grifols' Q3 2024 earnings call, several key financial metrics and strategic updates were discussed. The company reported a 12.4% increase in third-quarter revenue totaling nearly EUR 1.8 billion, with year-to-date revenues reaching EUR 5.2 billion, marking a 9.1% increase. Adjusted EBITDA for the quarter stood at EUR 462 million, equating to a margin of nearly 26% and an improvement of 26.7% from the prior year. Free cash flow improved to EUR 127 million, and the leverage ratio was reduced to 5.1x from 6.8x in the first quarter. The executives expressed confidence in meeting full-year guidance, supported by robust global demand and decreased plasma costs. Additionally, Grifols achieved significant advancements in innovation, including a U.S. BARDA contract and progress in regulatory processes for fibrinogen. They also highlighted enhancements in corporate governance and strategic management transitions, notably with the appointment of Rahul Srinivasan as CFO, aimed at improving financial discipline and operational efficiency.Strong Revenue Growth
Revenue in the third quarter totaled nearly EUR 1.8 billion, representing a 12.4% increase on a constant currency basis over the previous year, and year-to-date revenues reached EUR 5.2 billion, representing a 9.1% increase.
Significant EBITDA Improvement
Adjusted EBITDA for the quarter came in at EUR 462 million with a margin of nearly 26%, an improvement of 26.7% at constant currency from the previous year.
Successful Deleveraging
The company reduced its leverage ratio to 5.1x from 6.8x in the first quarter, showing strong momentum in deleveraging efforts.
Innovative Progress in Biopharma
The IG franchise showed double-digit growth with a remarkable 52% increase in subcutaneous IG year-to-date on a constant currency basis.
Strategic Contract Awarded
Grifols was awarded a U.S. BARDA contract worth up to $135 million over the next 6 years to develop a recombinant polyclonal antibody therapy.
---
DE:G0FB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:G0FB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | €8.00 | €8.05 | +0.63% |
| Jul 30, 2024 | €7.05 | €7.20 | +2.13% |
| May 14, 2024 | €6.10 | €6.30 | +3.28% |
| Feb 29, 2024 | €8.15 | €6.95 | -14.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Grifols SA (DE:G0FB) report earnings?
Grifols SA (DE:G0FB) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Grifols SA (DE:G0FB) earnings time?
Grifols SA (DE:G0FB) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Grifols SA stock?
The P/E ratio of Grifols SA is N/A.
What is DE:G0FB EPS forecast?
DE:G0FB EPS forecast for the fiscal quarter 2024 (Q4) is 0.22.
---